Introduction
Prostaglandin F2a (PGF2a), from the uterus, causes luteal regression in ewes (McCracken et al, 1972; Inskeep and Murdoch, 1980) . During luteal regression, PGF2o is secreted in a series of high amplitude, short duration pulses (Thorburn et al, 1973; Barcikowski et al, 1974; Fairclough et al, 1980; Webb et al, 1981; Flint and Sheldrick, 1983; Zarco et al, 1988a) . Oxy¬ tocin may play an important role in generating this pulsatile pattern of secretion (Flint et al, 1990) . Uterine PGF2a and luteal oxytocin exist in a positive feedback loop (Flint et al, 1986) . Each pulse of PGF2a may result from the activation of this feedback loop.
Maturation of the positive feedback loop for uterine PGF2a: luteal oxytocin may determine when pulsatile secretion of PGF2a occurs during the oestrous cycle. The ability of the uterus occurring in the intracellular regulatory systems that link the receptor to the synthesis and secretion of PGF2a (i.e. at the postreceptor level). Oxytocin stimulates activity of an endometrial phospholipase C (PLC) that can cleave phosphatidylinositol bisphosphate into diacylglycerol and inositol triphosphate (Flint et al, 1986; Silvia and Homanics, 1988) . Agonists of second messengers generated by activation of PLC stimulate release of PGF2a from endometrial tissue in vitro (Silvia and Homanics, 1988; Raw and Silvia, 1991) . Stimulation of synthesis and secretion of PGF2a by oxytocin, therefore, appears to be mediated through the activation of PLC. Changes in the ability of oxytocin to activate PLC could account for the changes in uterine secretory responsiveness to oxytocin observed during the oestrous cycle. Mirando et al. (1990a) showed that the ability of oxytocin to stimulate activity of PLC is much greater on day 16 than on day 12 after oestrus. However, it has not been determined whether this change in responsiveness of PLC precedes the onset of luteal regression. It is also possible that changes may occur, during the oestrous cycle, in the ability of the second messengers produced by PLC to activate synthesis ofPGF2Q.
Prostaglandins are synthesized from the fatty acid precursor, arachidonic acid. In many cell types, agonists that stimulate syn¬ thesis of prostaglandins do so by promoting the mobilization of arachidonic acid from phospholipid storage pools (Irvine, 1982) .
Oxytocin may have a similar effect in uterine tissue. The first step in prostaglandin synthesis is the peroxidation of arachi¬ donic acid to PGH2 by prostaglandin H endoperoxide synthase (PGS; Smith, 1989) . Changes in the ability of oxytocin to stimulate uterine secretion of PGF2a during the oestrous cycle may be due to changes in the concentration or activity of PGS. During early pregnancy, the pulsatile pattern of uterine PGF2a secretion is suppressed (Thorburn et al, 1973; Barcikowski et al, 1974; Nett et al, 1976; Peterson et al, 1976; Webb et al, 1981; Moore et al, 1982; Hooper et al, 1986; Zarco et al, 1988b) . One factor that may contribute to this suppression is a disruption of the uterine PGF2a: luteal oxytocin positive feedback loop. The ability of oxytocin to stimulate secretion of PGF2a on days 13-16 of pregnancy is much less than its ability to do so on corresponding days of the oestrous cycle (Fairclough et al, 1984; McCracken et al, 1984; Burgess et al, 1990; Silvia et al, 1992) . The increase in concentration of endometrial receptors for oxytocin associated with luteolysis in nonpregnant ewes does not occur in pregnant ewes (McCracken et al, 1984; Sheldrick and Flint, 1985) . However, changes in endometrial tissue occurring at the post-receptor level may also contribute to the suppression of endometrial secretory responsiveness to oxytocin during early pregnancy. The ability of oxytocin to stimulate activity of PLC on day 16 after oestrus was much lower in pregnant than in nonpregnant ewes (Mirando et al, 1990a) .
The objectives of this experiment were to characterize the changes that occur during the oestrous cycle and early preg¬ nancy in (1) the ability of oxytocin to stimulate activity of PLC, (2) the ability of caruncular endometrial tissue to release PGF2a in response to agonists of second messengers pro¬ duced by PLC and (3) the capacity of endometrial tissue to convert arachidonic acid to PGF2a. Changes in these variables were then related to changes in the ability of oxytocin to stimulate release of PGF2a during the oestrous cycle and early pregnancy.
Materials and Methods
Forty-three ewes were checked for oestrous behaviour twice daily (07:00 h and 17:00 h) with a vasectomized ram. After at least one oestrous cycle of normal duration (15.5-18.0 days), ewes were randomly assigned to one of two treatment groups: nonpregnant (n = 24) or bred (n = 19). Ewes assigned to the bred group were mated with an intact ram at oestrus (day 0).
Beginning on day 0, blood samples from the jugular vein were collected by venepuncture daily at 08:00 h until tissue collec¬ tion. Blood samples were allowed to clot for 12-24 h at 4°C. Serum was harvested and stored at -20°C until assayed.
Concentrations of progesterone were determined in these samples, to assess luteal function at the time of tissue collec¬ tion, using a commercial, solid-phase radioimmunoassay kit (Coat-a-Count, Diagnostic Products Corp., Los Angeles, CA) as described by Silvia et al (1992) . Samples were run in three assays. Intra-and interassay coefficients of variation were 8 and 5%, respectively.
Uteri were collected immediately after death from nonpregnant ewes on days 4-7 (n = 4), 10 (n = 4), 12 (n = 6), 14 (n = 5) or 16 (« = 5) and from bred ewes on days 12 (n = 8), 14 (n = 4) and 16 (n = 7) after oestrus. Ewes were killed by exsanguination after captive bolt concussion. For bred ewes, each uterine horn was flushed with 20 ml of Krebs-Hensleitbicarbonate buffer (KHB; 118 mmol NaCl 1, 4.7 mmol KC1 1, 2.56mmol CaCl2 \~\ 1.13 mmol MgCl2 \ 25 mmol NaHCOj \ 1.15 mmol NaH2P04 l"1, 5.55 mmol glucose l~\ 20 mmol Hepes 1~\ 0.013 mmol phenol red 1, pH 7.4) to recover embryos and confirm pregnancy. Thirty-six caruncular endometrial expiants (40-100 mg) were dissected from the uterus and placed in KHB. Expiants were weighed and trans¬ ferred to 12 75 mm borosilicate glass culture tubes contain¬ ing KHB and then incubated to measure activity of PLC or release of PGF,".
Assay for phospholipase C Four expiants were used to measure the activity of phospho¬ lipase C as described by Silvia and Homanics (1988) . Briefly, expiants were incubated in four successive periods lasting 90, 60, 5 and 30 min, respectively. During periods 1-3, expiants were prepared for measurement of phospholipase C activity. This consisted of labelling phosphatidylinositol bisphosphate by incubation of expiants with [3H]myo-inositol and inactiv¬ ación of endogenous inositol phosphate phosphatase by incu¬ bation with LiCl. All expiants were treated identically during periods 1-3. In period 4, two expiants from each ewe were incubated in 0.5 ml KHB, including 10 mmol LiCl I-* and 1 pmol 1_1 oxytocin. The remaining two expiants were incubated in LiCl-supplemented KHB to serve as controls. Incubations were terminated and [3H]inositoI phosphates (inositol tris-, bis-and monophosphates) extracted and measured as described by Silvia and Homanics (1988) . Activity of PLC was expressed as total inositol phosphates (c.p.m.) per gram of tissue.
Release of prostaglandin F2a
Thirty-two expiants from the same ewes were subjected to a similar, four-period, in vitro incubation protocol. Expiants were incubated in KHB during periods 1-3. In period 4, four expiants of each tissue type were incubated in 0.5 ml KHB with the fol¬ lowing additions: (1) no addition (control), (2) oxytocin (1 pmol 1_I), (3) arachidonic acid (20 mg 1_I), (4) oxytocin plus arachi¬ donic acid, (5) phorbol 12-myristate 13-acetate (PMA, 0.1 pmol 1), (6) A23187 (lpmol 1), (7) PMA plus A23187 or (8) indomethacin (10 mg l-1). Incubations were terminated and concentrations of PGF2a in incubation medium were measured by radioimmunoassay as described by Silvia and Homanics (1988) . The samples were run in 12 assays. The intra-and inter¬ assay coefficients of variation were 13 and 19%, respectively. The rate of release of PGF2a was expressed as ng min-1 g-1 wet tissue.
Pregnancy rate
Embryos were recovered from four of four bred ewes killed on day 14 and from four of seven ewes killed on day 16 after mating. A definitive embryo was recovered from only one of eight bred ewes killed on day 12. Tissue fragments that could have been from embryos were recovered from another three ewes. No embryos or fragments were recovered from the remaining four ewes. This low recovery rate on day 12 was not unusual or unexpected, particularly when dealing with ewes that had not been superovulated (Silvia and Niswender, 1986) .
We assumed that the pregnancy rate in the group killed on day 12 would be similar to that in those killed on days 14 and 16 (8 pregnant/11 bred; 73%) when embryos are more easily recovered. In a study conducted earlier in the breeding season (Silvia et al, 1992), using the same flock of ewes and the same rams under similar breeding conditions, the pregnancy rate was also 73% (33 pregnant/45 bred). Only six of the eight bred ewes killed on day 12 were therefore likely to have been pregnant. Since we had no conclusive evidence with which to identify the pregnant ewes, we considered all eight ewes to be pregnant and analysed the data accordingly.
Statistical analysis
For those ewes killed on day 14 or 16, the mean and standard deviation of the concentrations of progesterone in the five daily blood samples collected during the midluteal phase (days 8-12 after oestrus) were calculated. Ewes were defined as undergoing luteal regression if the concentration of progesterone in the sample collected immediately prior to death was more than two standard deviations below the mean of the midluteal phase. Luteal regression was defined as being completed if concentrations of progesterone had fallen below 1 ng ml~.
Release of PGF2a in the presence of indomethacin is pre¬ sumed to be due to the release of PGF2a synthesized prior to the onset of the final treatment incubation period. Indomethacinsuppressible release of prostaglandins (i.e. the difference between release from control expiants and release from indomethacintreated expiants) is assumed to represent release of PGF2a that depends on synthesis during the final incubation period. Since one objective of this investigation was to relate synthesis of PGF2a during the final incubation period to activity of PLC dur¬ ing the same period, values for release of prostaglandins from all other in vitro treatments have been adjusted by subtracting the release of PGF2a from the indomethacin-treated expiants for that ewe. On average, indomethacin suppressed release of PGF2a from expiants by 44%.
Effects of day after oestrus, pregnancy and oxytocin on activity of phospholipase C were determined by analysis of variance for a split-plot design. Effects of day after oestrus and pregnancy were considered main plots and oxytocin considered a subplot within ewe. Effects of day after oestrus, pregnancy and in vitro treatments on release of PGF2a were determined using analysis of variance for a split-plot design. Effects of day after oestrus and pregnancy were considered main plots and in vitro treatments (oxytocin and arachidonic acid, or PMA and A23187) considered subplots within ewe applied in a 2 2 factorial arrangement. When the initial analysis of variance indi¬ cated that it was appropriate, effects of in vitro treatment and day after oestrus were determined in pregnant and nonpregnant ewes, separately. All data were transformed logarithmically prior to analysis to reduce heterogeneity of variance among treatment groups. All analyses of variance were conducted using the General Linear Models procedure of SAS (1985) .
Results
Concentrations of progesterone up to the time of death were typical for ewes experiencing normal oestrous cycles. All ewes appeared to reach a normal level of luteal function (2-6 ng pro¬ gesterone ml-1) during the oestrous cycle of tissue collection.
On the basis of the statistical criteria described above, luteal regression had been completed in one of five nonpregnant ewes killed on day 14. The remaining four ewes were killed prior to the onset of luteolysis. Luteal regression had been completed in four of five ewes killed on day 16. The remaining ewe was killed during luteolysis.
When overall release of PGF2a is considered across in vitro treatment groups, an effect of day after oestrus was observed (P < 0.01, Fig. 1 ). Release of PGF2(I was relatively low on days 5 and 10. It increased successively on days 12 and 14, then decreased to an intermediate level by day 16. Release of PGF2a was enhanced by addition of arachidonic acid (P < 0.01) irres¬ pective of the day on which tissue was collected. The increase was relatively small on days 5 and 10. Release in the presence of arachidonic acid was much higher on days 12, 14 and 16 after oestrus. Release of PGF2a was stimulated by oxytocin on days 14 and 16 after oestrus (P < 0.01), but not at any earlier time points. The effects of arachidonic acid and oxytocin were additive (i.e. there was no oxytocin x arachidonic acid interaction).
A similar temporal pattern of release over the oestrous cycle was observed when release estimates were pooled across expiants receiving PMA or A23187 (Fig. 2 ). Release of PGF2a was enhanced by PMA (P < 0.01) and the response was consis¬ tent across days of the oestrous cycle (i.e. there were no inter¬ actions involving PMA and day after oestrus). A stimulatory effect of A23187 was also observed (P = 0.01); however, the response was affected by the day after oestrus (P = 0.02).
A23187 could induce an increase in release of PGF20 only from tissues collected on days 12 and 16 after oestrus (P < 0.09 and Fig. 1 . Rates of release of prostaglandin F2a (PGF2a) by ovine caruncu¬ lar endometrial tissue incubated in vitro, in the presence of control medium (D), 1 µ oxytocin 1_I ( ), 20 mg arachidonic acid l-1 (0) or oxytocin plus arachidonic acid ( ). Tissue was collected from non¬ pregnant ewes on days 4-7 (n = 4), 10 (n = 4), 12 (n = 6), 14 (n = 5) or 16 (n = 5) after oestrus. Bars represent antilog values of the leastsquares means of logarithmically transformed data. Lines above bars represent anti-log values of standard errors of the least-squares means. Different superscript letters denote significant differences in release due to day of tissue collection considered across in vitro treatment groups (P < 0.05). Fig. 2 . Rates of release of PGF2a by ovine caruncular endometrial tissue incubated in vitro, in the presence of control medium (D), 0.1 pmol phorbol 12-myristrate 13-acetate 1 (PMA) ( ), 1 pmol A23187 1 (0) or PMA plus A23187 ( ). Tissue was collected from nonpreg¬ nant ewes on days 4-7 (n = 4), 10 (n = 4), 12 (n = 6), 14 (n = 5) or 16 (n = 5) after oestrus. Bars represent antilog values of the leastsquares means of logarithmically transformed data. Lines above bars represent anti-log values of standard errors of the least-squares means. Different superscripts denote significant differences in release due to day of tissue collection considered across in vitro treatment groups (P < 0.05). = 0.01, respectively). Tissues collected at other times in the oestrous cycle did not respond to A23187 (P > 0.32). No interactions of PMA with A23187 were observed. Basal activity of PLC was low in tissues collected at all five points in the oestrous cycle (Fig. 3) . Oxytocin had no effect on activity of PLC in tissues collected on days 5, 10 or 12 after oestrus. Oxytocin stimulated activity of PLC on days 14 and 16 after oestrus (P = 0.06 and < 0.01, respectively). Stimulation was much greater on day 16 than on day 14 (P = 0.02). A relatively high level of PGF2a release was sustained from day 12 through day 16 of early pregnancy (Fig. 4 ). Release was comparable to that observed for tissues collected from non¬ pregnant ewes on day 12 after oestrus and much greater than release from tissues collected from nonpregnant ewes either on day 5 or 10 after oestrus. Release of PGF2a was enhanced by oxytocin (P < 0.01). Effects of pregnancy or interactions involving pregnancy and oxytocin were not observed implying that responses to oxytocin were similar in tissues from pregnant and nonpregnant ewes. Within the pregnant ewes, a slight but not significant oxytocin by day interaction was observed (P = 0.14) owing to the lower response to oxytocin observed in tissues collected on day 12 compared with days 14 or 16.
Addition of arachidonic acid to the incubation resulted in an increase in PGF2a release (P < 0.04) at all three times after oestrus. An interaction of arachidonic acid with pregnancy status was observed (P < 0.01). This appears to be due to a greater conversion of arachidonic acid to PGF2a by tissues from pregnant ewes, particularly when collected on days 14 and 16 after mating. An interaction of oxytocin with arachidonic acid was also observed (P < 0.01). This was probably due to the failure of oxytocin to consistently induce further stimulation of PGF2a release in the presence of arachidonic acid.
Within pregnant ewes, release of PGF2a was slightly but not significantly enhanced by both PMA and A23187 (P = 0.10 and = 0.06, respectively; Fig. 5 ). There were no interactions involving day after oestrus, PMA or A23187, implying that responses to PMA and A23187 were consistent across days. When release of PGF2a was considered across in vitro treatment groups, no difference in overall release was observed among days. When compared with nonpregnant ewes at comparable stages of the oestrous cycle, no effects of pregnancy or inter¬ actions involving pregnancy status were observed. Basal activity of PLC was low in tissues collected at all three stages of early pregnancy (Fig. 6 ). Oxytocin was not able to stimulate activity of PLC on any of the days examined.
Discussion
Release of PGF2a from caruncular endometrial expiants collected on days 5 or 10 of the oestrous cycle was very low. There was a dramatic increase in release from tissue collected on day 12 after oestrus. Maximum release was observed from tissues collected on day 14; there was then a decline in release from tissues collected on day 16. The temporal pattern of release of PGF2a from ovine caruncular observed in this study is similar to that described by Roberts et al (1976) . The ability of oxytocin to stimulate uterine release of PGF2o was evident on days 14 and 16 after oestrus. Roberts et al (1976) observed a weak secretory response to oxytocin from tissue collected on day 13 after oest¬ rus. A much more robust response was observed from tissues collected on day 15. Release was somewhat less from tissues collected on the day of oestrus. Very minimal responses to oxy¬ tocin were observed from tissues collected on days 3 or 5 after oestrus. The temporal pattern of responsiveness to oxytocin described in the experiment reported here and in the report of Roberts et al (1976) is in accord with previous reports describing changes in the ability of oxytocin to stimulate uterine secretion of PGF2a when administered in vivo at various points in the oestrous cycle (Roberts et al, 1975; Roberts and McCracken, 1976; Fairclough et al, 1984; Silvia et al, 1992) . The ability of endometrial tissue to convert added arachidonic acid to PGF2a was used as an indirect measure of PGS activity. This interpretation depends on the assumption that the relative conversion of PGH2 (the immediate end-product of PGS activity) to PGF2a rather than other prostaglandins is not altered by stage of the oestrous cycle or by pregnancy status. Endometrial tissue can convert arachidonic acid into several prostaglandins includ¬ ing PGE2 and PGI2. Uterine secretion of PGE2 is greater during early pregnancy than during the corresponding stages of the oestrus cycle (Silvia et al, 1984; Vincent and Inskeep, 1986) . This is reflected in the release of PGE2 by endometrial tissue in vitro (Ellinwood et al, 1979; Lacroix and Kann, 1982) . However, even in tissue from pregnant ewes, PGF2a release exceeds that of PGE2 by 4-5 times (Ellinwood et al, 1979; Hyland et al, 1982; Lewis and Waterman, 1985) . The rate of secretion of PGI2 from endometrial tissue is similar to that for PGF2a (Silvia et al, 1984; Lewis and Waterman, 1985) ; however, secretion does not appear to be affected by pregnancy status. It is therefore unlikely that the dramatic changes in PGF2a release in the presence of arachidonic acid reported here are due to increases in the formation of PGE2 or PGI2 at the expense of PGF2a. In this experiment, conversion of PGH2 to PGF2a was mini¬ mal on days 5 and 10 after oestrus. Conversion increased sub¬ stantially on day 12 and was maintained up to day 14, and then fell on day 16. Huslig et al (1979) measured PGS activity in homogenates of ovine endometrial tissue collected at various stages of the oestrous cycle. They observed an increase in total PGS activity beginning on day 13 after oestrus. This appeared to be due to an increase in the concentration of the enzyme rather than any change in its specific activity. More recently, Salamonsen and Findlay (1990) used an immunohistochemical procedure to demonstrate that the concentration of the enzyme increased on day 10 after oestrus and remained high until day 15. Taken together, these observations indicate that the synthe¬ sis of the enzyme increases prior to any change in enzymatic activity. An endogenous inhibitor of PGS activity may be present in endometrial tissue prior to day 12 after oestrus. The concentration of this inhibitor may decline after day 12 to allow endometrial synthesis of PGS. An inhibitor of PGS activity has been demonstrated in homogenates of bovine endometrial tis¬ sue and the changes in activity of this inhibitor throughout the oestrous cycle are compatible with such a regulatory role (Basu and Kindahl, 1987; Gross et al, 1988) . Clearly, increases in the concentration and activity of PGS occur well in advance of the increase in uterine secretory responsiveness to oxytocin that occurs on day 14.
Release of PGF2a from caruncular endometrial tissue in the presence of PMA or A23187 or both was used as a means of assessing the integrity of the intracellular regulatory mechanisms controlling PGF2a synthesis at various points in the oestrous cycle. The phorbol ester, PMA, induced a small but consistent increase in PGF2a release from endometrial tissues collected throughout the oestrous cycle. The Ca2+ ionophore A23187 could stimulate release of PGF2a only from tissues collected late in the oestrous cycle (days 12 and 16) and the response was again rather low. Its failure to stimulate release from tissues collected on day 14 is difficult to explain, particularly since oxy¬ tocin and PMA were both effective at this time. In a previous experiment with ovariectomized ewes receiving steroid replace¬ ment therapy (Raw and Silvia, 1991) , PMA and A23187 stimu¬ lated release of PGF2a but the response was also very small. The steroid-replacement protocol used in that experiment was designed to simulate steroid conditions during the latter portion of the luteal phase. In contrast, responses to PMA and A23187 were greater in tissues collected from ovariectomized ewes subjected to a steroid replacement protocol that was more rep¬ resentative of the late follicular phase or oestrus (Silvia and Homanics, 1988) . PMA (but not A23187) stimulated release of PGF2(J from bovine endometrial tissue collected on the day of oestrus (Lafrance and Goff, 1990) . Thus, responsiveness to PMA and A23187 appears to be characteristic of a uterus under oestrogenic dominance. Responses to these compounds may have limited relevance to the secretion of PGF2(1 that occurs prior to and during luteolysis, when the uterus is under the influence of progesterone.
The ability of oxytocin to stimulate activity of PLC was not observed until day 14 after oestrus. This coincides with the earliest time point at which oxytocin can stimulate release of PGF2a. This agrees with the report of Mirando et al. (1990a) that oxytocin could stimulate activity of PLC in endometrial tissue collected from ewes on day 16 but not on day 12 after oestrus. In the study reported here, maximum activity of PLC in response to oxytocin was observed in tissues collected on day 16. Even though a much higher level of PLC activity was observed on day 16 after oestrus, the amount of PGF2(J released in response to oxytocin (in excess of basal release) was similar on days 14 and 16. Clearly, the activity of PLC is not the sole factor limiting the amount of PGF2a produced in response to oxytocin. A similar conclusion was reached in an experiment with ovariectomized ewes receiving steroid replacement (Raw and Silvia, 1991) .
The increase in the ability of oxytocin to stimulate activity of PLC appears to be associated with the completion of luteal regression. As noted above, responsiveness to oxytocin is much greater in tissues collected on day 16 than on day 14. Only one of five nonpregnant ewes providing tissue on day 14 after oestrus had completed luteal regression. The increase in activity of PLC induced by oxytocin was six-fold greater in tissue from this ewe (30.7 X 103 c.p.m. g_I) than from the remaining four that had not yet initiated luteolysis (4.9 + 1.3 x 103 c.p.m. g"1 (mean + SEM)). Only one of five ewes killed on day 16 had not completed luteal regression. The increase in activity of PLC induced by oxytocin was much less in tissue from this ewe (13.8 x 103 c.p.m. g_I) than in tissue from the remaining four ewes that had completed luteal regression (53.0 + 17.5 X 10 c.p.m. g-1). On days 14 and 16, release of PGF2(1 induced by oxytocin tended to be greater from tissue collected before the completion of luteal regression. Thus, the lack of an association between activity of PLC and release of PGF2a is also observed within treatment groups. Responsiveness of endometrial PLC to oxytocin may develop as a consequence of luteolysis. The precise mechanism through which the corpus luteum inhibits endometrial PLC is not clear. Responsiveness of endometrial PLC to oxytocin can develop in ovariectomized ewes in the presence of continuous high concentrations of progesterone (Vallet and Bazer, 1989; Raw and Silvia, 1991) .
The ability of oxytocin to stimulate activity of PLC appears to correspond to changes in endometrial concentrations of receptors for oxytocin observed during the oestrous cycle (Sheldrick and Flint, 1985) . Concentrations of oxytocin recep¬ tors are relatively low throughout most of the oestrous cycle. The first reliably detectable increase in concentration occurs on day 14 after oestrus and concentrations continue to increase up to the day of oestrus. In contrast, the ability of oxytocin to stimulate release of PGF2a from endometrial tissue peaks on day 15 and then declines (Roberts et al, 1976; Silvia et al, 1992) . As with the activity of PLC, the relationship between the ability of oxytocin to stimulate release of PGF2a (both in vivo and in vitro) and the concentration of receptors for oxytocin appears to be weak. The apparent separation of PLC activity and release of PGF2a may be due to differences in cellular localization. The highest concentrations of PGS and its mRNA are found in epi¬ thelial cells (Raw et al, 1988; Eggleston et al, 1990;  Salamonsen and Findlay, 1990; Salamonsen et al, 1991), suggesting that synthesis of PGF occurs primarily within this layer. Receptors for oxytocin are present in the epithelial cells and in the under¬ lying caruncular stroma (Ayad et al, 1991; Wallace et al, 1991) . The increase in oxytocin receptors observed between days 14 and 16 after oestrus occurs mainly in the stroma. Perhaps the oxytocin-responsive PLC is also found in the stroma.
The release of PGF2a from caruncular endometrial expiants collected on days 12, 14 and 16 of early pregnancy was quite comparable to but more variable than that observed in non¬ pregnant ewes. The variability in secretion of PGF2a after administration of oxytocin in vivo is also greater in pregnant than in nonpregnant ewes (Burgess et al, 1990; Silvia et al, 1992) . Oxytocin was equally effective in stimulating release of PGF2o[ from endometrial tissue collected from pregnant and nonpregnant ewes. This is in sharp contrast to the inability of oxytocin to stimulate secretion of PGF2a from the uterus when administered in vivo to ewes on days 12 to 16 of pregnancy (Fairclough et al, 1984; McCracken et al, 1984; Silvia et al, 1992) . The reason why oxytocin can stimulate release of PGF2(J from endometrial tissue in vitro but not in vivo is not clear.
Apparently, the continuous presence of the conceptus is required for this suppression. In the present study, incubation of uterine tissue, in the absence of the conceptus for just 2.5 h, appears to be sufficient time for the suppressive effect of the conceptus to wear off. This implies that some extremely labile factor is involved in mediating the suppressive effect. The conceptus may suppress uterine secretion of PGF2o through its secretion of ovine trophoblast protein-1 (oTP-1). Ovine TP-1 is an interferon-like protein that has been shown to delay luteal regression when infused into the uterus (Godkin et al, 1984;  Vallet et al, 1988) . It may delay luteolysis through its ability to suppress oxytocin-induced secretion of PGF2o from the uterus (Vallet et al, 1988; Mirando et al, 1990b) . Acute exposure of dispersed, ovine endometrial cells to oTP-1 or recombinant human interferon-a in vitro suppressed spontaneous release of PGF2a (Salamonsen et al, 1988 (Salamonsen et al, , 1989 ). Perhaps oTP-1 or some other conceptus-secreted product promotes the synthesis of a labile factor which exerts an inhibitory action at some point in the intracellular regulatory pathways controlling synthesis of PGF2a. In the absence of oTP-1, the rate of synthesis of the factor declines such that biologically active concentrations cannot be maintained.
The ability of endometrial tissue from pregnant ewes to convert arachidonic acid to PGF2a was not impaired during early pregnancy. Salamonsen and Findlay (1990) found no differences in immunohistochemically detectable PGS in endo¬ metrial tissue collected from pregnant and nonpregnant ewes on day 15 after oestrus. Thus, the conceptus does not appear to suppress secretion of PGF2a by reducing the concentration or activity of PGS in endometrial tissue.
The stimulatory effects of PMA and A23187 on release of PGF2a were relatively small in magnitude and similar to the responses observed in nonpregnant ewes at comparable stages after oestrus. The biological significance of these effects is not clear. As reported by Mirando et al. (1990a, b) , the ability of oxytocin to stimulate activity of PLC was totally suppressed in pregnant ewes. The mechanism by which the conceptus sup¬ presses activation of PLC by oxytocin is unclear. Chronic ad¬ ministration of oTP-1 to nonpregnant ewes reduced the ability of oxytocin to stimulate activity of PLC (Mirando et al, 1990a, b). Yet, acute exposure of ovine endometrial tissue to oTP-1 in vitro had very little effect on the ability of oxytocin to stimulate activity of PLC (Vallet and Bazer, 1989 ). Since oTP-1 was effective in suppressing release of PGF2a under similar conditions in vitro, it seems unlikely that the inhibitory effect of the conceptus on PLC is exerted by oTP-1 directly.
The failure of oxytocin to stimulate activity of PLC in tissue from pregnant ewes is surprising, particularly in light of the fact that oxytocin could stimulate release of PGF2a very effec¬ tively. Taken together, these data (the very limited stimulatory effects of PMA and A23187 and the discrepancies between activity of PLC and release of PGF2a in tissue from pregnant and non-pregnant ewes) indicate that the stimulatory effects of oxytocin on secretion of PGF2a are mediated through a mechanism other than one involving an increase in activity of phosphatidylinositol-specific PLC.
A relationship between activity of PLC and receptors for oxytocin is very apparent in pregnant ewes. Concentrations of receptors for oxytocin are maintained at low, luteal-phase levels up to day 19 of early pregnancy (McCracken et al, 1984; Sheldrick and Flint, 1985) , as is the ability of oxytocin to stimu¬ late activity of PLC. These animals have low concentrations of receptors for oxytocin, show no increase in activity of PLC in response to oxytocin, yet release PGF2o in response to an oxytocin challenge in vitro. It seems unlikely that a substantial increase in the concentration of receptors for oxytocin could have occurred during the 2.5 h preincubation period. Recently, a dissociation between the concentration of oxytocin receptors and the ability of oxytocin to stimulate uterine secretion of PGF2a has been demonstrated in ewes (Vallet and Lamming, 1990; Vallet et al, 1990) . We therefore suggest that the ability of oxytocin to stimulate release of PGF2a from endometrial tissue probably requires a relatively low, luteal-phase concen¬ tration of receptors for oxytocin. The amount of PGF2(1 released by endometrial tissue in response to oxytocin is probably determined by factors at the post-receptor level.
